Permanent and reversible genetic modifications are important approaches to study gene function in different cell types. They are also important for stem cell researchers to explore and test the therapeutic potential of stem cells. The piggyBac transposon from insects is a rising nonviral system that efficiently mutagenizes and mediates gene transfer into the mammalian genome. It is also characterized by its precise excision, leaving no trace sequence behind so that the genomic integrity of the mutated cell can be restored. Here, we use an optimized piggyBac transposon system to mediate gene transfer and expression of a bifunctional fluorescent reporter in human embryonic stem (ES) cells. We provide molecular evidence for transposase-mediated piggyBac integration events and functional evidence for successful expression of a transferred fluorescent protein genes in human ES cells and their in vitro differentiated derivatives. We also demonstrate that the integrated piggyBac transposon can be removed and an undisrupted insertion site can be restored, which implies potential applications for its use in gene therapy and genetics studies.
Get full access to this article
View all access options for this article.
References
1.
ThomsonJA, Itskovitz-EldorJ, ShapiroSS, WaknitzMA, SwiergielJJ, MarshallVS, JonesJM. 1998. Embryonic stem cell lines derived from human blastocysts. Science, 282:1145–1147.
2.
ReubinoffBE, PeraMF, FongCY, TrounsonA, BongsoA. 2000. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol, 18:399–404.
3.
ZwakaTP, ThomsonJA. 2003. Homologous recombination in human embryonic stem cells. Nat Biotechnol, 21:319–321.
4.
DavisRP, NgES, CostaM, MossmanAK, SourrisK, ElefantyAG, StanleyEG. 2008. Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors. Blood, 111:1876–1884.
5.
ZwakaTP, ThomsonJA. 2005. Differentiation of human embryonic stem cells occurs through symmetric cell division. Stem Cells, 23:146–149.
6.
ChiaoE, ElazarM, XingY, XiongA, KmetM, MillanMT, GlennJS, WongWH, BakerJ. 2008. Isolation and transcriptional profiling of purified hepatic cells derived from human embryonic stem cells. Stem Cells, 26:2032–2041.
7.
DuanY, CatanaA, MengY, YamamotoN, HeS, GuptaS, GambhirSS, ZernMA. 2007. Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo. Stem Cells, 25:3058–3068.
8.
AndersonD, SelfT, MellorIR, GohG, HillSJ, DenningC. 2007. Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol Ther, 15:2027–2036.
9.
XueH, WuS, PapadeasST, SpustaS, SwistowskaAM, MacarthurCC, MattsonMP, MaragakisNJ, CapecchiMR, RaoMS, ZengX, LiuY. 2009. A targeted neuroglial reporter line generated by homologous recombination in human embryonic stem cells. Stem Cells, 27:1836–1846.
10.
RubyKM, ZhengB. 2009. Gene targeting in a HUES line of human embryonic stem cells via electroporation. Stem Cells, 27:1496–1506.
PlacantonakisDG, TomishimaMJ, LafailleF, DesbordesSC, JiaF, SocciND, VialeA, LeeH, HarrisonN, TabarV, StuderL. 2009. BAC transgenesis in human embryonic stem cells as a novel tool to define the human neural lineage. Stem Cells, 27:521–532.
13.
ZWDu, HuBY, AyalaM, SauerB, ZhangSC. 2009. Cre recombination-mediated cassette exchange for building versatile transgenic human embryonic stem cells lines. Stem Cells, 27:1032–1041.
14.
UrbachA, SchuldinerM, BenvenistyN. 2004. Modeling for Lesch–Nyhan disease by gene targeting in human embryonic stem cells. Stem Cells, 22:635–641.
15.
ZouJ, MaederML, MaliP, Pruett-MillerSM, Thibodeau-BegannyS, ChouBK, ChenG, YeZ, ParkIH, DaleyGQ, PorteusMH, JoungJK, ChengL. 2009. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell, 5:97–110.
16.
van der WeydenL, AdamsDJ, BradleyA. 2002. Tools for targeted manipulation of the mouse genome. Physiol Genomics, 11:133–164.
WatanabeK, UenoM, KamiyaD, NishiyamaA, MatsumuraM, WatayaT, TakahashiJB, NishikawaS, MugurumaK, SasaiY. 2007. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol, 25:681–686.
19.
SmithJR, MaguireS, DavisLA, AlexanderM, YangF, ChandranS, ffrench-ConstantC, PedersenRA. 2008. Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration. Stem Cells, 26:496–504.
20.
ThyagarajanB, LiuY, ShinS, LakshmipathyU, ScheyhingK, XueH, EllerstromC, StrehlR, HyllnerJ, RaoMS, ChesnutJD. 2008. Creation of engineered human embryonic stem cell lines using phiC31 integrase. Stem Cells, 26:119–126.
21.
LombardoA, GenoveseP, BeausejourCM, ColleoniS, LeeYL, KimKA, AndoD, UrnovFD, GalliC, GregoryPD, HolmesMC, NaldiniL. 2007. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol, 25:1298–1306.
22.
VieyraDS, GoodellMA. 2007. Pluripotentiality and conditional transgene regulation in human embryonic stem cells expressing insulated tetracycline-ON transactivator. Stem Cells, 25:2559–2566.
23.
JangJE, ShawK, YuXJ, PetersenD, PepperK, LutzkoC, KohnDB. 2006. Specific and stable gene transfer to human embryonic stem cells using pseudotyped lentiviral vectors. Stem Cells Dev, 15:109–117.
24.
WilberA, LinehanJL, TianX, WollPS, MorrisJK, BelurLR, McIvorRS, KaufmanDS. 2007. Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer. Stem Cells, 25:2919–2927.
25.
SCWu, MeirYJ, CoatesCJ, HandlerAM, PelczarP, MoisyadiS, KaminskiJM. 2006. PiggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells. Proc Natl Acad Sci USA, 103:15008–15013.
26.
FeschotteC. 2006. The piggyBac transposon holds promise for human gene therapy. Proc Natl Acad Sci USA, 103:14981–14982.
27.
DingS, WuX, LiG, HanM, ZhuangY, XuT. 2005. Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell, 122:473–483.
28.
WilsonMH, CoatesCJ, GeorgeALJr. 2007. PiggyBac transposon-mediated gene transfer in human cells. Mol Ther, 15:139–145.
29.
MitraR, Fain-ThorntonJ, CraigNL. 2008. piggyBac can bypass DNA synthesis during cut and paste transposition. EMBO J, 27:1097–1109.
30.
YantSR, ParkJ, HuangY, MikkelsenJG, KayMA. 2004. Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells. Mol Cell Biol, 24:9239–9247.
31.
LiX, HarrellRA, HandlerAM, BeamT, HennessyK, FraserMJJr. 2005. piggyBac internal sequences are necessary for efficient transformation of target genomes. Insect Mol Biol, 14:17–30.
32.
LoisC, HongEJ, PeaseS, BrownEJ, BaltimoreD. 2002. Germline transmission and tissue-specific expression of trans-genes delivered by lentiviral vectors. Science, 295:868–872.
33.
ChungJH, WhiteleyM, FelsenfeldG. 1993. A 5′ element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell, 74:505–514.
34.
ArangoNA, Lovell-BadgeR, BehringerRR. 1999. Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development. Cell, 99:409–419.
35.
ChenYT, LiuP, BradleyA. 2004. Inducible gene trapping with drug-selectable markers and Cre/loxP to identify developmentally regulated genes. Mol Cell Biol, 24:9930–9941.
36.
CadinanosJ, BradleyA. 2007. Generation of an inducible and optimized piggyBac transposon system. Nucleic Acids Res, 35:e87.
ChoDI, QuanW, OakMH, ChoiHJ, LeeKY, KimKM. 2007. Functional interaction between dopamine receptor subtypes for the regulation of c-fos expression. Biochem Biophys Res Commun, 357:1113–1118.
39.
HadjantonakisAK, PapaioannouVE. 2004. Dynamic in vivo imaging and cell tracking using a histone fluorescent protein fusion in mice. BMC Biotechnol, 4:33.
40.
RheeJM, PirityMK, LackanCS, LongJZ, KondohG, TakedaJ, HadjantonakisAK. 2006. In vivo imaging and differential localization of lipid-modified GFP-variant fusions in embryonic stem cells and mice. Genesis, 44:202–218.
41.
HasegawaK, CowanAB, NakatsujiN, SuemoriH. 2007. Efficient multicistronic expression of a transgene in human embryonic stem cells. Stem Cells, 25:1707–1712.
42.
SzymczakAL, WorkmanCJ, WangY, VignaliKM, DilioglouS, VaninEF, VignaliDA. 2004. Correction of multi-gene deficiency in vivo using a single “self-cleaving”. 2A peptide-based retroviral vector. Nat Biotechnol, 22:589–594.
43.
LiangQ, KongJ, StalkerJ, BradleyA. 2009. Chromosomal mobilization and reintegration of Sleeping Beauty and PiggyBac transposons. Genesis, 47:404–408.
44.
MooreR, CaiKQ, EscuderoDO, XuXX. 2009. Cell adhesive affinity does not dictate primitive endoderm segregation and positioning during murine embryoid body formation. Genesis, 47:579–589.
YusaK, RadR, TakedaJ, BradleyA. 2009. Generation of transgene-free induced pluripotent mouse stem cells by the pig-gyBac transposon. Nat Methods, 6:363–369.
47.
KajiK, NorrbyK, PacaA, MileikovskyM, MohseniP, WoltjenK. 2009. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature, 458:771–775.
48.
PaddisonPJ, SilvaJM, ConklinDS, SchlabachM, LiM, ArulebaS, BalijaV, O'ShaughnessyA, GnojL, ScobieK, ChangK, WestbrookT, ClearyM, SachidanandamR, McCombieWR, ElledgeSJ, HannonGJ. 2004. A resource for large-scale RNA-interference-based screens in mammals. Nature, 428:427–431.
49.
MaragathavallyKJ, KaminskiJM, CoatesCJ. 2006. Chimeric Mos1 and piggyBac transposases result in site-directed integration. FASEB J, 20:1880–1882.
50.
YantSR, HuangY, AkacheB, KayMA. 2007. Site-directed transposon integration in human cells. Nucleic Acids Res, 35:e50.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
